Cargando…
A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis
Introduction Mucormycosis is a rare opportunistic fungal infection caused by fungi belonging to the Mucorales order and Mucoraceae family. It ranks as the third most prevalent angioinvasive fungal infection, following aspergillosis and candidiasis. This severe infection typically affects individuals...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684971/ https://www.ncbi.nlm.nih.gov/pubmed/38034231 http://dx.doi.org/10.7759/cureus.47932 |
_version_ | 1785151525894488064 |
---|---|
author | S, Anbumathi Govindarajan, Karthikeyan S, Yogesh Parivallal, Pranav Lokesh G Hariharan, Sathyanarayana Khaleel, Atif SB, Praveen T Goswami, Katyayani Saravanan, Pushpa Panneerselvam, Dharmarajan |
author_facet | S, Anbumathi Govindarajan, Karthikeyan S, Yogesh Parivallal, Pranav Lokesh G Hariharan, Sathyanarayana Khaleel, Atif SB, Praveen T Goswami, Katyayani Saravanan, Pushpa Panneerselvam, Dharmarajan |
author_sort | S, Anbumathi |
collection | PubMed |
description | Introduction Mucormycosis is a rare opportunistic fungal infection caused by fungi belonging to the Mucorales order and Mucoraceae family. It ranks as the third most prevalent angioinvasive fungal infection, following aspergillosis and candidiasis. This severe infection typically affects individuals with compromised immune systems, including those with hematological malignancies like leukemia and lymphoma, individuals who have undergone stem cell transplants, and people with diabetes mellitus. Individuals in good health are rarely affected, making immunocompromised individuals particularly vulnerable to this potentially fatal fungal disease. The aim of this study was to perform a comparative analysis of survivors versus non-survivors among diabetes patients admitted with mucormycosis. Methodology This was a descriptive observational study. A total of 338 patients were enrolled in the study. The study variables included demographics, COVID-19 infection, diabetes mellitus history, steroid use, use of oxygen support, and steam inhalation. Results Of the total 338 patients enrolled in the study, 253 (74.9%) were male and 85 (25.01%) were female. The number of survivors were 305 (90.2%) and non-survivors were 33(9.8%). The mean age of survivors was 52.50 ± 11.31 and non-survivors was 54.06 ± 8.54 years. Patients who underwent steam inhalation had a higher chance of survival compared to those who did not undergo steam inhalation and this association was statistically significant (p=0.01). Males showed a higher chance of survival (93.7%) as compared to females (80.0%). The associations between oxygen support, steroid use, and COVID-19 infection with the survival status were statistically non-significant. Conclusion There was a strong association between the history of steam inhalation and the outcome of mucormycosis among diabetes patients admitted with mucormycosis. Female patients demonstrated a higher fatality rate than males indicating a significant gender disparity observed in cases. Our findings may help to better identify and treat patients who are at higher risk for severe forms of mucormycosis. |
format | Online Article Text |
id | pubmed-10684971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-106849712023-11-30 A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis S, Anbumathi Govindarajan, Karthikeyan S, Yogesh Parivallal, Pranav Lokesh G Hariharan, Sathyanarayana Khaleel, Atif SB, Praveen T Goswami, Katyayani Saravanan, Pushpa Panneerselvam, Dharmarajan Cureus Endocrinology/Diabetes/Metabolism Introduction Mucormycosis is a rare opportunistic fungal infection caused by fungi belonging to the Mucorales order and Mucoraceae family. It ranks as the third most prevalent angioinvasive fungal infection, following aspergillosis and candidiasis. This severe infection typically affects individuals with compromised immune systems, including those with hematological malignancies like leukemia and lymphoma, individuals who have undergone stem cell transplants, and people with diabetes mellitus. Individuals in good health are rarely affected, making immunocompromised individuals particularly vulnerable to this potentially fatal fungal disease. The aim of this study was to perform a comparative analysis of survivors versus non-survivors among diabetes patients admitted with mucormycosis. Methodology This was a descriptive observational study. A total of 338 patients were enrolled in the study. The study variables included demographics, COVID-19 infection, diabetes mellitus history, steroid use, use of oxygen support, and steam inhalation. Results Of the total 338 patients enrolled in the study, 253 (74.9%) were male and 85 (25.01%) were female. The number of survivors were 305 (90.2%) and non-survivors were 33(9.8%). The mean age of survivors was 52.50 ± 11.31 and non-survivors was 54.06 ± 8.54 years. Patients who underwent steam inhalation had a higher chance of survival compared to those who did not undergo steam inhalation and this association was statistically significant (p=0.01). Males showed a higher chance of survival (93.7%) as compared to females (80.0%). The associations between oxygen support, steroid use, and COVID-19 infection with the survival status were statistically non-significant. Conclusion There was a strong association between the history of steam inhalation and the outcome of mucormycosis among diabetes patients admitted with mucormycosis. Female patients demonstrated a higher fatality rate than males indicating a significant gender disparity observed in cases. Our findings may help to better identify and treat patients who are at higher risk for severe forms of mucormycosis. Cureus 2023-10-29 /pmc/articles/PMC10684971/ /pubmed/38034231 http://dx.doi.org/10.7759/cureus.47932 Text en Copyright © 2023, S et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism S, Anbumathi Govindarajan, Karthikeyan S, Yogesh Parivallal, Pranav Lokesh G Hariharan, Sathyanarayana Khaleel, Atif SB, Praveen T Goswami, Katyayani Saravanan, Pushpa Panneerselvam, Dharmarajan A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis |
title | A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis |
title_full | A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis |
title_fullStr | A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis |
title_full_unstemmed | A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis |
title_short | A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis |
title_sort | comparative study on survivors versus non-survivors among diabetic patients having mucormycosis |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684971/ https://www.ncbi.nlm.nih.gov/pubmed/38034231 http://dx.doi.org/10.7759/cureus.47932 |
work_keys_str_mv | AT sanbumathi acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT govindarajankarthikeyan acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT syogesh acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT parivallalpranavlokeshg acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT hariharansathyanarayana acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT khaleelatif acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT sbpraveent acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT goswamikatyayani acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT saravananpushpa acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT panneerselvamdharmarajan acomparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT sanbumathi comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT govindarajankarthikeyan comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT syogesh comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT parivallalpranavlokeshg comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT hariharansathyanarayana comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT khaleelatif comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT sbpraveent comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT goswamikatyayani comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT saravananpushpa comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis AT panneerselvamdharmarajan comparativestudyonsurvivorsversusnonsurvivorsamongdiabeticpatientshavingmucormycosis |